Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Roche, Boehringer tap biosensor firms for patient studies
Pharmaphorum
Thu, 01/26/23 - 10:58 am
Tags:
Roche
,
Boehringer Ingelheim
,
patient monitoring
,
biosensors
,
clinical trials
,
Sysnav Healthcare
,
Strados Labs
Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Tags:
Sanofi
,
FDA
,
clinical trials
,
hemophilia A
,
efanesoctocog alfa
,
Roche
,
Hemlibra
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
Tags:
immuno-oncology
,
oncology
,
subcutaneous drug delivery
,
Keytruda
,
Merck
,
Tecentriq
,
Roche
Roche’s Tecentriq to be filed for early-stage liver cancer
Pharmaphorum
Thu, 01/19/23 - 09:41 am
Tags:
Roche
,
Tecentriq
,
Avastin
,
clinical trials
,
liver cancer
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
Tags:
FDA
,
drug approvals
,
Mounjaro
,
Eli Lilly
,
Vabysmo
,
Roche
,
Opdualag
,
Bristol Myers Squibb
,
Carvykti
,
JNJ
,
Vtama
,
Roivant
,
Pluvicto
,
Novartis
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop
Fierce Pharma
Mon, 01/16/23 - 11:16 am
Tags:
Merck
,
Keytruda
,
Roche
,
cancer
,
oncology
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
Tags:
pharma stocks
,
Amgen
,
BeiGene
,
Bristol Myers Squibb
,
Gilead Sciences
,
Lantheus Holdings
,
Madrigal Pharmaceuticals
,
Merck
,
Moderna Therapeutics
,
Novo Nordisk
,
Prometheus Biosciences
,
Roche
Roche searches for pharma chief Anderson's successor from within: chairman
Fierce Pharma
Fri, 01/13/23 - 10:54 am
Tags:
Roche
,
Bill Anderson
Three TIGIT players look to surprise in 2023
EP Vantage
Fri, 01/13/23 - 10:06 am
Tags:
anti-TIGIT
,
Roche
,
Merck
,
Gilead Sciences
,
Arcus Biosciences
JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals
Fierce Pharma
Tue, 01/10/23 - 10:50 am
Tags:
JPMHC 2023
,
Takeda
,
vaccines
,
Roche
,
GSK
,
Bayer
,
Merck
Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact
Fierce Biotech
Mon, 01/9/23 - 10:39 am
Tags:
Kronos Bio
,
biobucks
,
AML
,
Roche
,
Genentech
,
small molecule drugs
,
drug discovery
FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate
Endpoints
Sun, 01/8/23 - 09:59 pm
Tags:
FDA
,
priority review
,
Pfizer
,
Prevnar 20
,
vaccines
,
Roche
,
bispecific antibodies
,
glofitamab
,
lymphoma
Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal
Fierce Biotech
Fri, 01/6/23 - 09:33 am
Tags:
Roche
,
Genentech
,
Nimble Therapeutics
,
biobucks
,
drug discovery
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Tags:
Pfizer
,
Merck
,
JNJ
,
Novartis
,
AbbVie
,
Roche
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
Wed, 01/4/23 - 10:11 am
Tags:
FDA
,
drug approvals
,
HIV
,
lymphoma
,
multiple sclerosis
,
Gilead Sciences
,
Roche
,
TG Therapeutics
Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma
Fierce Pharma
Wed, 12/28/22 - 08:32 pm
Tags:
Roche
,
FDA
,
Lunsumio
,
gene therapy
,
follicular lymphoma
Roche takes over development of Biogen-partnered lymphoma drug
BioPharma Dive
Tue, 12/20/22 - 11:11 am
Tags:
Roche
,
Biogen
,
lymphoma
,
glofitamab
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
Tags:
clinical trials
,
Acadia Pharmaceuticals
,
Argenx
,
Arrowhead Pharmaceuticals
,
Biomarin
,
BioNTech
,
Daiichi Sankyo
,
Day One
,
EQRx
,
Fate Therapeutics
,
FibroGen
,
Gilead Sciences
,
Idorsia
,
Immunogen
,
Intellia Therapeutics
,
Karuna Therapeutics
,
Moderna Therapeutics
,
Regeneron
,
Roche
,
Travere Therapeutics
,
Vaxcyte
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
Pfizer
,
Roche
,
CSL
,
uniQure
,
Novo Nordisk
,
Eli Lilly
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
Tags:
AstraZeneca
,
Alexion
,
PNH
,
Ultomiris
,
Soliris
,
Roche
,
Apellis
,
Novartis
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.